The Potential Hepatocyte Differentiation Targets and MSC Proliferation by FH1
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70601 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Sang Luo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Beijing National Biochip Research Center Sub-Center in Ningxia, Institute of Medical Sciences, General Hospital of Ningxia Medical Univ…. Hauptthemen laut MEDLINE: Hepatocytes, Mesenchymal Stem Cells, Cell Differentiation, Small Molecule Libraries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ningxia Medical University School-Level Research Project, Science and Technology Support Project of Yinchuan.
Abstract (Originalsprache)
The main cause of acute liver failure (ALF) is hepatocellular necrosis, which induces liver repair dysfunction and leads to high mortality. In recent years, studies have increasingly shown that stem cell‐derived hepatocyte‐like cells (HLCs) can be used for treatment in animal models of ALF. Notably, a hepatocyte differentiation strategy based on the small‐molecule compound functional hit 1 (FH1) successfully replaces HGF to promote the maturation of HLCs, but the underlying mechanism is still unclear. In this study, we used network pharmacology analysis to clarify the important role of the HGF/c‐Met signalling pathway in FH1‐induced hepatocyte (FH1‐iHeps) differentiation. After FH1 was added to mesenchymal stem/stromal cells (MSCs), proliferation and cell cycle progression were rescued by treatment with a tyrosine kinase (c‐Met) inhibitor. Additionally, c‐Met signalling in MSCs was significantly increased by treatment with FH1, as shown by the increased c‐Met, p‐p38, p‐AKT and p‐ERK1/2 protein levels. FH1‐iHeps efficiently improved the liver function of mice with acute liver injury and prolonged their lifespan. These data provide new insight into the mechanisms regulating the stemness properties of human umbilical cord‐derived stem cells (hUC‐MSCs) and reveal a previously unrecognised link between FH1 and c‐Met in directing hepatocyte differentiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Beijing National Biochip Research Center Sub-Center in Ningxia, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, China.
- Ningxia Regional Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Regional High Incidence Disease, Yinchuan, China.
- Key Laboratory of Ministry of Education for Fertility Preservation and Maintenance, Ningxia Medical University, Yinchuan, China.
- Department of Gynecology, General Hospital of Ningxia Medical University, Yinchuan, China.
ORCID-Profile: Sang Luo
Förderung
- Ningxia Medical University School-Level Research Project
- Science and Technology Support Project of Yinchuan
Zitieren
APA
Luo, S., Wu, F., Jin, Y., & Liu, D. (2025). The Potential Hepatocyte Differentiation Targets and MSC Proliferation by FH1. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70601
Vancouver
Luo S, Wu F, Jin Y, Liu D. The Potential Hepatocyte Differentiation Targets and MSC Proliferation by FH1. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70601
BibTeX
@article{Luo2025,
author = {Luo, Sang and Wu, Fang and Jin, Yiran and Liu, Dan},
title = {The Potential Hepatocyte Differentiation Targets and MSC Proliferation by FH1},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70601}
}
EUVIMED